WellSpace Health Residential and Withdrawal Management

WellSpace Health Residential and Withdrawal Management

Services:
Facility Operation (e.g., Private, Public)
• Private non-profit organization

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Facility Vaping Policy

• Vaping permitted in designated area

Gender Accepted

• Male
• Female

Special Programs/Groups Offered

• Adult women
• Adult men

Detoxification (medical withdrawal) Services

• Cocaine Detoxification
• Methamphetamines detoxification
• Medication routinely used during detoxification
• Alcohol Detoxification
• Opioids detoxification

Transitional Services

• Discharge Planning
• Aftercare/continuing care
• Naloxone and overdose education
• Outcome follow-up after discharge

Payment/Insurance/Funding Accepted

• SAMHSA funding/block grants
• Cash or self-payment
• Medicaid
• Federal, or any government funding for substance use treatment programs

Age Groups Accepted

• Young Adults
• Adults

External Opioid Medications Source

• In-network prescribing entity

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Ancillary Services

• Case management service
• Early intervention for HIV
• Social skills development
• Suicide prevention services
• Transportation assistance

License/Certification/Accreditation

• State Substance use treatment agency
• The Joint Commission
• State department of health

Testing

• Drug or alcohol urine screening
• Drug and alcohol oral fluid testing
• Breathalyzer or blood alcohol testing

Recovery Support Services

• Mentoring/peer support
• Employment counseling or training
• Housing services
• Self-help groups

Facility Smoking Policy

• Smoking permitted in designated area

Treatment Approaches

• Brief intervention
• Matrix Model
• Motivational interviewing
• Relapse prevention
• Substance use disorder counseling
• Cognitive behavioral therapy
• Anger management
• Trauma-related counseling

Type of Care

• Substance use treatment
• Detoxification

Assessment/Pre-treatment

• Screening for substance use
• Comprehensive substance use assessment
• Outreach to persons in the community
• Screening for tobacco use

Type of Opioid Treatment

• Lofexidine or Clonidine detoxification
• Buprenorphine detoxification
• Prescribes naltrexone
• Accepts clients using MAT but prescribed elsewhere
• Relapse prevention with naltrexone
• Buprenorphine maintenance
• Prescribes buprenorphine
• Maintenance service with medically supervised withdrawal after stabilization

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Short-term residential
• Residential detoxification
• Long-term residential
• Residential/24-hour residential

Education and Counseling Services

• Health education services other than HIV/AIDS or hepatitis
• Substance use disorder education
• Individual counseling
• Group counseling
• HIV or AIDS education, counseling, or support

Pharmacotherapies

• Naltrexone (oral)
• Lofexidine
• Clonidine
• Buprenorphine without naloxone
• Buprenorphine sub-dermal implant
• Buprenorphine (extended-release, injectable)
• Naltrexone (extended-release, injectable)
• Buprenorphine with naloxone